Key result
Atrial natriuretic peptides induce diuresis and reduce blood pressure across cardiovascular and renal diseases.
Why the study?
Research on the physiological role of atrial peptides in man is limited, and the potential for these peptides or stable analogues in therapeutics is uncertain.
Atrial natriuretic peptides play a key physiological role in fluid and hemodynamic regulation, highlighting their potential as therapeutic targets for heart failure, renal failure, and hypertension.
Answers are grounded in this paper and cite their sources.
Supports ANP-targeted therapies in HF and hypertension; leaves open clinical adoption pending randomized trials.
Research on the physiological role of atrial peptides in man is limited, and the potential for these peptides, or more stable analogues, in therapeutics is uncertain. It is clear, however, that plasma levels of immunoreactive atrial natriuretic peptide (IR-ANP) are increased in volunteers taking a high sodium diet, and are elevated in patients with heart failure, chronic renal failure, and primary aldosteronism. There is suggestive evidence that IR-ANP levels are increased also in essential hypertension, although overlap with normotensives is considerable. Injection or infusion of atrial peptides into man results in a diuresis, an increased output of urine electrolytes, a fall in blood pressure and a rise in heart rate, suppression of aldosterone and sometimes of renin also, and stimulation of norepinephrine. In essential hypertensives, urinary effects may be greater than in normotensives. Heart failure patients show a rise in cardiac output and falls in both systemic and pulmonary arterial pressure. Over the next few years and especially if specific antagonists can be developed, the physiologic and pathophysiologic roles of atrial peptides in normal man and in clinical disorders should be clarified. It is possible that stable analogues of atrial peptides will find a place in the treatment of cardiac failure, renal failure, and perhaps hypertension.
No takes yet. Share an insight, caveat, or question.
Nicholls et al. (1987) conducted a review in Heart failure, chronic renal failure, primary aldosteronism, essential hypertension. Atrial natriuretic peptides was evaluated. Atrial natriuretic peptides induce diuresis, increase urine electrolytes, and lower blood pressure, highlighting their physiological role and potential therapeutic use in cardiovascular and renal diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: